The Fattal chain is buying up apartment buildings in Tel Aviv in response to the challenge from Airbnb.
One year into the job, Teva CEO Kare Schultz has halted the plunge in the company's share price and restored investor confidence, but what of the future?
The results of the US midterm elections appear to mean business as usual, particularly for Israel.
A startup is almost always just another small company that gets nowhere. If anything, startup is a synonym for failure, not an exit.
The company founded six years ago to develop the valuable real estate in and around Israel's stations has achieved nothing.
DLA Piper Canada partner Adv. Noam Goodman and iCan founder Saul Kaye speak to "Globes" about the cannabis opportunities Israel is missing.
Yuri Milner made his money from social networks. Now his Breakthrough awards support science - in Israel too.
Egyptian President el-Sisi: Egypt will buy gas from all eastern Mediterranean gas fields.
UBS Impact Investment Strategist Nicole Neghaiwi talks to "Globes" about how investment decisions can, and must, help make the world a better place.
CEO Aharon Lutzky talks about the $400 million medical cannabis company's special business model, and its ambitions.
The pre-Brexit budget contains interesting innovations, and measures that Israelis with UK connections should note.
Dan Hotels deputy chairman Ami Federmann: Link is for tourists who want the city rather than the beach.
The 8400 project aims to do for Israel's healthcare industry what the IDF's 8200 unit has done for cybersecurity.
Israeli medical companies are tackling the problem of obesity.